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Abstract
Nontyphoidal Salmonellae commonly cause invasive disease in African children that is
often fatal. The clinical diagnosis of these infections is hampered by the absence of a clear
clinical syndrome. Drug resistance means that empirical antibiotic therapy is often ineffec-
tive and currently no vaccine is available. The study objective was to identify risk factors for
mortality among children presenting to hospital with invasive Salmonella disease in Africa.
We conducted a prospective study enrolling consecutive children with microbiologically-con-
firmed invasive Salmonella disease admitted to Queen Elizabeth Central Hospital, Blantyre,
in 2006. Data on clinical presentation, co-morbidities and outcome were used to identify chil-
dren at risk of inpatient mortality through logistic-regression modeling. Over one calendar
year, 263 consecutive children presented with invasive Salmonella disease. Median age
was 16 months (range 0–15 years) and 52/256 children (20%; 95%CI 15–25%) died. Nonty-
phoidal serovars caused 248/263 (94%) of cases. 211/259 (81%) of isolates were multi-
drug resistant. 251/263 children presented with bacteremia, 6 with meningitis and 6 with
both. Respiratory symptoms were present in 184/240 (77%; 95%CI 71–82%), 123/240
(51%; 95%CI 45–58%) had gastrointestinal symptoms and 101/240 (42%; 95%CI 36–49%)
had an overlapping clinical syndrome. Presentation at <7 months (OR 10.0; 95%CI 2.8–
35.1), dyspnea (OR 4.2; 95%CI 1.5–12.0) and HIV infection (OR 3.3; 95%CI 1.1–10.2) were
independent risk factors for inpatient mortality. Invasive Salmonella disease in Malawi is
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characterized by high mortality and prevalence of multi-drug resistant isolates, along with
non-specific presentation. Young infants, children with dyspnea and HIV-infected children
bear a disproportionate burden of the Salmonella-associated mortality in Malawi. Strategies
to improve prevention, diagnosis and management of invasive Salmonella disease should
be targeted at these children.
Author summary
Nontyphoidal Salmonellae are a major, yet often neglected, cause of fatal invasive disease
among young African children, responsible for over 100,000 deaths a year. There is cur-
rently a lack of prospective studies to understand the clinical presentation and course of
this disease. Diagnosis can be confusing, antibiotic resistance is an increasing problem
and no vaccine is available. Studying 263 consecutive cases of invasive nontyphoidal Sal-
monella disease over a one year period, we observed disparate clinical presentations, pre-
cluding the possibility of making a reliable clinical diagnosis in cases of this disease. We
confirmed high mortality rates, finding that young age, dyspnea and HIV infection are
independent risk factors for death. These findings support both the need for improved
measures for prevention, diagnosis and management of invasive nontyphoidal Salmonella
disease and indicate which children with this disease are at most need of intensive clinical
care.
Introduction
Invasive bacterial disease is a major cause of mortality among African children [1–4]. Prospec-
tive studies from rural-based district hospitals in Kenya and Mozambique have found commu-
nity-acquired bacteremia to be responsible for 26% [1] and 21% [3] of pediatric inpatient
deaths. Pneumococcus and nontyphoidal Salmonellae (NTS) are the most common causes of
bacteremia among African children [1–5]. While the burden of disease due to pneumococcus
should fall with implementation of pneumococcal conjugate vaccines, no vaccine is available
or in clinical trials against invasive nontyphoidal Salmonella (iNTS) disease [6, 7].
iNTS disease among African children is caused primarily by Salmonella enterica serovars
Typhimurium and Enteritidis [8–12], and has an associated case fatality of around 20–25% for
bacteremia [8, 9, 11, 13, 14] and 52% for meningitis [15]. These findings contrast with Salmo-
nella disease in industrialized nations which typically presents as self-limiting enterocolitis,
rarely requiring hospitalization [16]. Despite reports of declining iNTS disease with falling
prevalence of malaria from specific African sites [17–19], recently published data from multi-
ple countries across sub-Saharan Africa indicate that NTS continues to be a major cause of
childhood bacteremia in west [20,21], central [22], east [23,24] and southern Africa [25,26].
The Phase 3 RTS,S/AS01 malaria vaccine trial conducted in eleven sites across sub-Saharan
Africa, agnostic to levels of Salmonella bacteremia, found an incidence of approximately 500
cases of Salmonella sepsis/100,000 children/year among children under two years [27]. Recent
data from the Typhoid Surveillance in Africa Program across a further seven sub-Saharan Afri-
can sites confirm that iNTS disease continues to be a major public health problem in the region
[28].
The clinical presentation of iNTS disease is often a non-specific febrile illness [7–10, 14].
Further diagnostic challenges result from the association of iNTS disease with other co-
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morbidities [7–10, 14]. Among African children, iNTS disease often occurs with malaria [29–
31], HIV [26, 31], malnutrition [32] and anemia [33]. In adults, there is a strong association
with HIV infection [26, 34]. Increasing multi-drug resistance among iNTS isolates in Africa
adds to the high attrition from iNTS disease [8, 10–12]. For Malawian isolates, 90% have been
reported as resistant to ampicillin, chloramphenicol and cotrimoxazole [35].
We set out to provide data to guide improved management of children with iNTS disease.
Consecutive microbiologically-confirmed cases admitted to a large government hospital in
Malawi were studied for the relationship between clinical presentation and outcome.
Methods
Study site
Queen Elizabeth Central Hospital (QECH) is the largest hospital in Malawi. It is situated in
Blantyre, one of the two main cities in Malawi, and serves a combined urban and peri-urban
rural population of around 1 million. The hospital has approximately 1000 beds and admits
around 10,000 adults and 30,000 children (<16 years) annually. Since 1996, the Malawi-Liver-
pool-Wellcome Trust Clinical Research Programme has performed blood and cerebrospinal
fluid (CSF) cultures from patients admitted with suspected sepsis and meningitis.
Study patients and clinical methods
Eligible participants were children age 14 years admitted to the Pediatric Department of
QECH with isolation of Salmonella from blood and/or CSF between January 1st and Decem-
ber 31st 2006. Subjects not meeting all three eligibility criteria were excluded. In order to
reduce bias due to early death following admission, children were approached for recruitment
on the day that Gram-negative bacteria were first detected in the blood or CSF, either on initial
Gram stain or following positive culture.
First-line antimicrobial therapy for suspected sepsis in children at the time of the study was
intramuscular chloramphenicol and gentamicin, or penicillin and gentamicin. The great
majority of Gram-negative bacteraemias detected were due to NTS, and these bacteria were
almost all resistant to chloramphenicol and penicillin. Therefore, children were started on oral
ciprofloxacin and/or intravenous ceftriaxone as soon as Gram-negative bacteria were first
detected. Once the organism and antibiotic sensitivity profile were known, treatment would be
amended as necessary.
First line antimicrobial therapy for pediatric meningitis was intravenous ceftriaxone.
Demographic and clinical data collected on admission were recorded on standard forms,
along with weight and height or length. Clinical progress was recorded daily through to dis-
charge from hospital or inpatient death.
Respiratory distress was defined as the presence of a tracheal tug, intercostal or subcostal
recession, head-bobbing or nasal flaring. Tachypnea and tachycardia on admission were
defined as rates greater than the 90th centile for age [36]. Children with an admission axillary
temperature >37.5˚C were classified as febrile. Children were considered to have gastroenteri-
tis if diarrhea (3 loose stools per day) or vomiting were present, and respiratory disease if
there was shortness of breath or respiratory distress. Fever without focus was defined as fever
in the absence of localizing clinical signs.
Severe malnutrition in children 6–60 months was defined as a weight-for-height greater
than 3 z-scores below the WHO median, or bilateral pedal edema (kwashiorkor). In children
over 60 months, severe malnutrition was defined as a body mass index (BMI)-for-age greater
than 3 z-scores below the WHO median. Severe anemia was defined as a packed cell volume
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(PCV) <15% or a hemoglobin concentration <5.0 g/dl. Hypoglycemia was defined as a glu-
cose concentration on admission <3.0 mmol/L.
Sampling and laboratory methods
Blood and CSF cultures were performed using a standard aerobic bottle (BacT/Alert, bioMe´r-
ieux, France) using 1–2 ml of blood and 0.5–1 ml of CSF. Following detection of Gram-negative
bacteria, Salmonellae were confirmed by biochemical testing with API 20E kits (bioMe´rieux)
and serovar was determined using agglutinating antisera (Prolab Diagnostics). Antimicrobial
susceptibility testing was performed by disc diffusion using ampicillin, chloramphenicol, cotri-
moxazole, gentamicin, ceftriaxone and ciprofloxacin discs according to British Society of Anti-
microbial Chemotherapy methods and breakpoints. The laboratory participates in the UK
National External Quality Assurance Scheme. All children admitted to QECH have a malaria
parasite slide and PCV performed. Full blood counts were determined using a HMX (Becton
Coulter). Tests for HIV infection were with Determine (Abbot Laboratories) and UniGold
(Trinity Biotech) rapid tests, following national Voluntary Counseling and Testing guidelines.
For discordant results and children under 18 months with positive results, the diagnosis was
confirmed by polymerase chain reaction for proviral DNA.
Rainfall data
Monthly rainfall data through 2006 were collected from the meteorological station at Chileka
Airport, Blantyre.
Statistical analysis
Data were entered into a Microsoft Access database and analysis was performed using R
(http://www.R-project.org/). Variation with age and season, of clinical indices, co-morbid-
ity and outcome, were calculated as Mantel-Haenszel odds ratios. To facilitate this, age was
converted into four ordinal categories (0–6 months, 7–12 months, 1–2 years, >2 years).
Presentation season was grouped as January-March, April-June, July-September and Octo-
ber-December and ranked by mean rainfall. Odds ratios of case fatality given the presence
of clinical indices or co-morbidity adjusted for age and season of presentation were calcu-
lated by logistic regression. Finally, a model of case fatality was constructed and tested by
multivariate logistic regression. Covariates were chosen for the first fit of the model if they
predicted mortality with a p value <0.1 along with age and sex. To minimize the number of
covariate patterns, age was collapsed into a binary variable (children 0–6 months and chil-
dren 7 months and over) for the purposes of the model. Covariates with the largest remain-
ing p value (but retaining age and sex) were sequentially removed from the model and the
model re-evaluated for goodness-of-fit and distribution of residuals at each step. The model
was also evaluated for two-way interactions between significantly-associated terms. Missing
data were addressed by providing denominator information where applicable.
Ethics statement
After ensuring that each child was on appropriate antimicrobial therapy, the study was explai-
ned to the parents or guardians and informed written consent obtained. Ethical approval for
the study was granted by the College of Medicine Research and Ethics Committee, College of
Medicine, University of Malawi.
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Results
In total, 4535 blood cultures and 1823 CSF cultures were performed on children admitted to
QECH over one year in 2006. Gram-negative organisms were detected in 395/4535 (9%) blood
cultures and 34/1823 (2%) CSF cultures. Of these, 257/395 (65%) and 12/34 (35%), respec-
tively, were identified as Salmonellae (Fig 1A). Salmonellae were isolated from both blood and
CSF of six children, giving a total of 263 episodes of invasive Salmonella disease. The majority
of Salmonellae 234/263 (89%) were serovar Typhimurium, while 14/263 (5%) were serovar
Enteritidis and only 8/263 (3%) Typhi. 7/263 (3%) could not be typed with locally available
antisera. Nine children had either a single (n = 5) or double (n = 4) recurrence of NTS bacter-
emia. NTS bacteraemia occurred in two sets of twins.
Of the 263 children with microbiologically-confirmed invasive Salmonella disease, 35 (13%)
had died and 23 (9%) been discharged prior to recruitment, leaving 205 (78%) whose parents
and guardians were approached for consent. Consent was obtained for 178 (87%) out of the
205 children seen (Fig 1B). Median age of children was 16 months (range 0 months to 15
Fig 1. Malawian children admitted to hospital with invasive Salmonella disease, recruitment and outcomes. (A) Blood and CSF
cultures taken from children admitted to Queen Elizabeth Central Hospital, Blantyre, Malawi in 2006; those yielding Salmonella isolates;
and outcomes of children with invasive Salmonella disease. (B) Recruitment pathway for children following detection of Gram-negative
bacteria in blood and/or CSF culture. (C) Kaplan-Meier estimate of survival (in days) of children following admission with invasive
Salmonella disease.
https://doi.org/10.1371/journal.pntd.0006027.g001
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years) with 213/263 (81%) under 3 years (Table 1 and Fig 2A). The incidence of disease was
associated significantly with rainfall (linear regression coefficient 4.70, 95% CI 2.48–6.92,
p = 0.001), with 152/263 (58%) presenting between January and March during the rainy season
(which last from November to April), and 30/263 from June to September in the dry season
(11%) (Fig 2B). 7/263 (3%) children self-discharged or were not admitted.
Clinical presentation
Clinical features and comorbidities of children with invasive Salmonella disease are shown in
Table 2 and Fig 2. Most children presented with a history of fever and were febrile on admis-
sion. Cough was significantly more common as a presenting symptom than either diarrhea
(p<0.001) or vomiting (p<0.001), with signs of respiratory distress in 72/166 (43%) of chil-
dren at admission. Older children (7 months) tended to present more often with fever in
isolation than younger children (<7 months; OR = 1.26, 95% CI 1.02–2.20). Neither the pro-
portions of respiratory nor gastrointestinal presentations varied with age (Fig 2E), and clinical
presentation did not vary significantly with season of presentation (Fig 2F).
45/180 (25%) of patients were severely malnourished. Median PCV on admission was 25%,
and 47/244 (19%) of children were severely anemic. 38/249 (15%) had concurrent Plasmodium
falciparum parasitemia. Of children tested, 70/162 (43%) were HIV-infected. Significantly
more older children (7 months) were HIV-infected than younger children (<7 months,
OR = 1.55; 95% CI 1.15–2.09). Malaria and malnutrition did not vary significantly with age
(Fig 2C). Children diagnosed with iNTS disease during the months with high rainfall were less
likely to be HIV-infected than those admitted in the dry season (OR = 0.67; 95% CI 0.49–0.89).
The rates of malaria and malnutrition did not vary significantly with season (Fig 2D).
Antimicrobial resistance and usage
Most strains were resistant to ampicillin, cotrimoxazole and chloramphenicol (multi-drug
resistant; 211/259, 81.5%). None were resistant to ciprofloxacin or ceftriaxone. Only 15/244
(6%) of children received first-line antimicrobials on admission to which their Salmonella iso-
late was susceptible in vitro. Conversion to either ceftriaxone or ciprofloxacin occurred with a
median delay of 3 days (range 1–12 days).
Mortality
Inpatient mortality was 52/256 (20%) (Fig 1C), highest among infants of 0 to 6 months inclu-
sive (53%) (Fig 2A), and declined with increasing age (OR = 0.56, 95%CI 0.42–0.75; age in this
model was divided into four ordinal categories, children 0–6 months, 7–12 years, 13–24
Table 1. Characteristics of children presenting with invasive Salmonella disease.
Age (months), median (range) 16 (0–180)
Number Percentage (95% CI)
Male 144/263 54.8 (48.7–60.8)
Inpatient mortality 52/256 20.3 (15.4–25.3)
HIV 70/162 43.2 (35.5–50.9)
Severe malnutrition 45/180 25.0 (18.6–31.4)
Malaria 38/249 15.3 (10.8–19.8)
MDR isolate 211/259 81.5 (76.7–86.2)
Abbreviations: CI, confidence interval; MDR, multidrug resistant.
https://doi.org/10.1371/journal.pntd.0006027.t001
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months, and >24 months). Mortality did not vary significantly with season (Fig 2B). Death
occurred on the calendar day of admission in 8/52 (15%) of children who died, with a median
time from admission to death of 3 days (range 0–18 days). Adjusting for age and season,
Fig 2. Variability in outcome, co-morbidity and clinical presentation of invasive Salmonella disease in Malawian children with age and season of
presentation. Graphs indicate variation in mortality (A and B), co-morbidity (C and D) and clinical presentation (E and F) with age and month of the year.
Each plot is overlaid on a histogram of the frequency of iNTS disease presentation with age (A, C and E) or bar-charts indicating monthly frequency of iNTS
disease and monthly rainfall (B, D and F).
https://doi.org/10.1371/journal.pntd.0006027.g002
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significant risk factors for mortality were: a history of dyspnea, absence of fever, presence of
respiratory distress or hypoglycemia at presentation, and HIV infection (Table 2). CPT was
not associated with mortality in HIV-infected children (OR = 2.17, 95%CI = 0.54–10.88;
p = 0.30). 147/204 (72%) of children surviving their acute admission were followed up four to
six weeks post-discharge from hospital (median time to follow up: 43 days), with no reported
deaths in the intervening time. Only one out of the nine children with recurrent NTS bacter-
emia died.
A logistic regression model predicting mortality including age, sex, HIV status and a history
of dyspnea was shown to be statistically significant (likelihood ratio test χ2 = 21.69, p = 0.0002)
with a pseudo-R2 of 0.179. The Hosmer-Lemeshow goodness-of-fit test for the model provides
no evidence to reject the model (p = 0.73) and the distribution and influence of the residuals
(S1 Fig) demonstrate that the model is consistent with the data. In this model, age less than 7
months (OR = 10.0; 95% CI 2.8–35.1), HIV infection (OR = 3.3, 95% CI 1.1–10.2) and a
Table 2. Clinical characteristics of Malawian children with invasive Salmonella disease and associated mortality.
Risk of deatha
Number (%) Odds Ratio (95% CI) p value
Symptoms
Fever 229/243 (94.2) 0.21 (0.06–0.69) 0.010
Convulsions 22/234 (9.4) 0.86 (0.23–3.13) 0.813
Vomiting 91/241 (37.8) 1.38 (0.70–2.72) 0.347
Diarrhea 75/241 (31.1) 1.70 (0.86–3.39) 0.128
Cough 167/234 (71.4) 1.83 (0.78–4.33) 0.163
Dyspnea 96/228 (42.1) 3.97 (1.90–8.31) <0.001
Signs
Febrile 184/227 (81.1) 0.62 (0.27–1.41) 0.257
Tachycardiab 46/67 (68.7) 2.30 (0.54–9.78) 0.261
Tachypneab 50/76 (65.8) 1.95 (0.54–7.01) 0.305
BCS<5 25/231 (10.8) 2.23 (0.86–5.80) 0.099
Dehydration 24/222 (10.8) 1.22 (0.45–3.33) 0.697
Candida 42/234 (17.9) 0.86 (0.35–2.11) 0.741
Respiratory distress 72/166 (43.4) 3.42 (1.48–7.89) 0.004
Hepatomegaly 52/232 (22.4) 1.21 (0.53–2.73) 0.649
Splenomegaly 62/231 (26.8) 0.51 (0.21–1.23) 0.137
Investigations
Severe anemia 47/244 (19.3) 0.94 (0.40–2.22) 0.884
Hypoglycemia 9/49 (18.4) 12.20 (2.04–72.78) 0.006
Co-morbidity
Malaria 38/249 (15.3) 0.75 (0.29–1.97) 0.565
HIV 70/162 (43.2) 3.56 (1.25–10.08) 0.017
Severe Malnutrition 45/180 (25.0) 1.93 (0.74–5.03) 0.176
Pathogen
MDR isolate 211/259 (81.5) 1.07 (0.45–2.61) 0.888
aAdjusted for age and season.
bEstimates of children with tachypnea and tachycardia are based on the small numbers of children for which respiratory rates and heart rates were
documented on presentation (n = 76 & 67).
CI denotes confidence interval.
Abbreviations: BCS, Blantyre Coma Score; MDR, multidrug resistant.
https://doi.org/10.1371/journal.pntd.0006027.t002
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history of dyspnea (OR = 4.2; 95% CI 1.5–12.0) were significant independent risk factors for
death. Inpatient survival in children with and without each of these risk factors for mortality is
presented in Fig 3.
Discussion
Salmonellae are a common cause of invasive disease in African children that is often fatal. The
clinical features and high mortality in the current study are unchanged from a retrospective
study from the same hospital a decade earlier [37]. Almost all patients had nontyphoidal sero-
vars, most commonly Typhimurium, and the majority of isolates were MDR. In some settings,
particularly urban centers, typhoid fever is more common than iNTS disease [12,24].
Invasive Salmonella disease occurred mainly in children under three years of age and, as
previously reported, was more common in the rainy season [8, 9, 21, 35]. In 206/240 (86%) of
children, the disease presented with fever together with respiratory symptoms, gastrointestinal
symptoms or both of these (Fig 4A). Since a clinical diagnosis of invasive Salmonella disease is
not reliable, laboratory detection of Salmonellae from blood or CSF by microbiological culture
is required. Facilities for this are uncommon in African hospitals and, even where present, a
diagnosis usually takes a minimum of 48 hours. Despite NTS being primarily considered an
enteric pathogen, the majority of children presented with cough or shortness of breath, com-
monly in the absence of enteric symptoms, as previously observed [8–10, 38].
This partly explains why the large majority of children with iNTS disease did not receive
empirical antimicrobials with good anti-Salmonella activity on admission. Conversion to an
antimicrobial regimen with adequate Salmonella cover occurred with a median delay of 3 days
from presentation, by which time half of the observed deaths had occurred. Therefore, in set-
tings where NTS are responsible for a large proportion of invasive pediatric bacterial infec-
tions, empirical antimicrobial therapy for suspected bacteremia and sepsis should take into
account local antimicrobial sensitivity of NTS. There has been a decline in antimicrobial resis-
tance among iNTS isolates in recent years, but the majority of S. Typhimurium were still mul-
tidrug resistance in 2014. A small number of Salmonella isolates with altered susceptibility to
ciprofloxacin and 3rd-generation cephalosporins have been reported in recent years [39].
Fig 3. Survival of children with invasive Salmonella disease. Kaplan-Meier estimates of survival (in days) following admission with invasive
Salmonella disease in children aged 0–6 months and >6 months (A), children with and without HIV co-infection (B), and children with and without a history
of dyspnea at presentation (C).
https://doi.org/10.1371/journal.pntd.0006027.g003
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The rapid demise of Malawian children with iNTS disease is similar to findings from Kenya
[9]. This is a major challenge for the management of children presenting with a syndrome
indistinguishable from severe pneumonia, for which WHO guidelines recommend the use of
ampicillin and chloramphenicol [38]. Early deaths also increase the difficulty of studying iNTS
disease, as children will often die before a microbiological diagnosis of Gram-negative bacter-
emia or meningitis is possible. This potential confounder can only be overcome by recruiting
every child at the time of admission. With up to 400 pediatric admissions a day at QECH, this
was not a feasible option in our setting.
Even in clinical facilities with diagnostic laboratories and appropriate antimicrobial ther-
apy, the burden of iNTS disease remains high. Until a vaccine against iNTS disease becomes
available and widespread immunization of children across sub-Saharan Africa is implemented,
development of a rapid diagnostic that can identify children with iNTS disease in a timely
manner should remain a public health priority. First-generation tests would be unlikely to pro-
vide information on antimicrobial resistance. Multidrug resistance (defined as resistance to
ampicillin, chloramphenicol and cotrimoxazole) is common among NTS blood culture isolates
across Africa [40, 41]. Therefore, in countries where conventional microbiological surveillance
and antimicrobial resistance testing are lacking, treatment of NTS in the absence of informa-
tion on antimicrobial resistance should avoid these antibiotics.
The possible emergence of new antimicrobial resistance patterns underlies the ongoing
need for blood culture surveillance data with antimicrobial resistance testing. Owing to the
ability of Salmonella to sequester in the intracellular niche within macrophages and cause
latent/recrudescent infection, antibiotics with good intracellular penetration, such as cipro-
floxacin, are advisable. The lack of reported deaths in the four to six week follow-up period
emphasizes the importance and value of providing intensive clinical care to children with
iNTS disease through their acute admission.
Fig 4. Clinical presentation and comorbidities of invasive Salmonella disease and mortality in Malawian children. (A) Area-proportionate Venn
diagram indicating the different presenting clinical syndromes of pediatric invasive Salmonella disease. Gastroenteritis is defined as children with a history
of diarrhea or vomiting, and a respiratory presentation as the presence of cough, shortness of breath or respiratory distress. (B) Area-proportionate Venn
diagram indicating comorbidities (HIV, malaria and severe malnutrition) of children presenting with invasive Salmonella disease. Figures are absolute
numbers (percentages in brackets) of children in each group, with mortality in each group given below and are shown for individual variables and for children
in whom these overlapped. Discrepancies between totals in the figures and the text are due to children with missing data for one of the categories depicted.
https://doi.org/10.1371/journal.pntd.0006027.g004
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Comorbidity was common, with 86/139 (62%) of children presenting with at least one of: P.
falciparum parasitemia, severe malnutrition or HIV infection (Fig 3B). Only 38/249 (15%) had
concurrent parasitemia, fewer than has been reported previously [8, 9]. In contrast to previous
reports [21], this proportion did not vary significantly with season, suggesting other reasons
for seasonal fluctuation in iNTS disease cases, such as worsening sanitation during the rainy
season facilitating transmission. We did not test for recent malaria, e.g. by detection of HRP2
in plasma. Recent malaria can be more strongly associated with iNTS disease in children than
current malaria [9]. Hemolysis-mediated immunological defects [42], which predispose chil-
dren with malaria to iNTS disease, persist for several weeks following parasite clearance [43].
The dominant co-morbidity was HIV infection, affecting 70/162 (43%) of the children in
the study. This greater proportion than has been reported previously [8, 9], likely reflects the
systematic testing for HIV infection in the study. In other studies, HIV testing has often only
been performed on a subset of children where HIV/AIDS has been suspected clinically (for
example [1]). The significance of HIV infection as a risk factor for iNTS disease may vary
across Africa, being more important in Southern and Eastern Africa compared with Western
Africa owing to regional differences in HIV prevalence.
Background prevalence of HIV infection among children in Malawi at the time of the study
was not known. However, available data of antenatal HIV prevalence and the numbers of chil-
dren living with HIV in Malawi at the time of the study, suggest that the prevalence for the
group under-five years was less than 2% [44]. Data on HIV status were only available for 161/
263 (61%) of the children, so these findings should be viewed with some caution. Nevertheless,
proportionately more children who died lacked HIV data (29/52, 56%), as compared to those
who survived (66/204, 32%; p = 0.003 for comparison of proportions), and so the association
of HIV with mortality may underestimate the prevalence of HIV co-infection.
This study aimed to identify the children in whom iNTS disease is most likely to be fatal.
Children with HIV infection, those with a history of dyspnea, and children under 7 months of
age are all at significantly increased risk of dying. The odds of dying with iNTS disease are 10
times greater in children under 7 months than they are in older children. This substantially-
increased risk of mortality in young infants is particularly striking (Fig 3A) and is observed in
spite of a significantly lower prevalence of HIV infection in this age group. Immune naivety is
the most likely reason. Infants are at particular risk of iNTS disease after maternally-acquired
antibody is lost and before they produce their own NTS-specific antibodies [45–47].
The dyspnea associated with increased risk of dying is most likely due to metabolic acidosis
resulting from Salmonella sepsis, or to bona fide Salmonella respiratory tract infection. Arterial
blood gas and anion gap measurements were not available, and chest radiographs not com-
monly performed in these children. Hence, it was not possible to distinguish the underlying
pathological mechanism. A history of shortness of breath often results in a child being misclas-
sified as suffering from pneumonia in resource-poor healthcare settings [38], increasing the
chance of children in this high risk subgroup receiving inappropriate empirical antimicrobials.
Although the association between HIV and iNTS disease is well established, the underlying
mechanisms of HIV infection as a determinant of mortality in children with iNTS disease has
not been well explored. Immunological defects in HIV-infected adults leading to susceptibility
to iNTS disease include impaired gut mucosal immunity [48], and dysregulated cellular [49]
and humoral immunity [50, 51]. The mechanisms that contribute to increased mortality in
children with iNTS disease and HIV provide important questions for future research, which
should explore the key interaction of HIV infection and malnutrition [31].
Only three children at presentation were receiving anti-retroviral therapy (ART), while 37
were on cotrimoxazole preventive therapy (CPT). CPT has been shown to protect against
iNTS in HIV-infected African adults prior to the use of ART [52] and subsequent studies have
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shown benefit of CPT in protecting against invasive bacterial disease in communities with
high levels of in vitro cotrimoxazole resistance [53]. However, CPT prophylaxis did not affect
outcome in our study among HIV-infected children with iNTS disease. Recent work has indi-
cated an important role for the introduction of ART among HIV-infected African children in
reducing the incidence of iNTS disease [26, 31], but has yet to show that ART improves out-
come among HIV-infected children with iNTS disease [31].
Limitations
The main limitation of the study is that these data were collected from one site during one
period in time, the calendar year 2006. New prospective studies from other sites in sub-Saha-
ran Africa would be valuable for confirming the reproducibility of our findings across the
region and their ongoing applicability to iNTS disease in Africa. In Blantyre, the epidemiology
of invasive Salmonella disease changed markedly in 2011 with the start of an epidemic of
typhoid fever. By 2012 S. Typhi was a more common blood culture isolate than NTS [39], indi-
cating the fluidity of the epidemiology of invasive Salmonella disease in one site.
Additionally, iNTS disease has declined in Blantyre, accompanied by reductions in malaria,
HIV (following the successful implementation of an antiretroviral therapy program beginning
in 2005) and acute malnutrition [31]. Nevertheless, across sub-Saharan Africa, iNTS disease
remains the commonest presentation of invasive Salmonella disease and a major cause of pedi-
atric bacteremia [2,8,27].
Conclusions
This prospective study provides additional evidence that iNTS disease is common and fre-
quently fatal among children in sub-Saharan Africa, and particularly highlights the major diag-
nostic and management challenges associated with iNTS disease [7]. iNTS disease does not
present with a readily-identifiable clinical syndrome and current empirical antimicrobials do
not provide effective treatment for Salmonella infections. Empirical antimicrobial treatment
for potential Salmonella infection should be considered for children presenting with a clinical
syndrome compatible with systemic infection. This is especially true for children with HIV
infection and young infants, and particularly applies to presentations suggestive of commu-
nity-acquired pneumonia in regions where invasive Salmonella disease is common.
The development of cheap rapid diagnostic tests for iNTS disease in children should be a
priority. The poor effectiveness of antimicrobials means that other approaches to treatment
are required. Epidemiological studies provide strong evidence that antibodies bactericidal to
iNTS in the presence of complement protect against these infections [45, 46]. The development
and use of a vaccine that induces protective antibodies in young infants may provide effective
protection [6, 7].
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